FRANKLIN LAKES, N.J., Nov. 5, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.784 billion for the fourth fiscal quarter ended September 30, 2020. This represents an increase of 4.4% over the prior-year period on both a reported and currency-neutral basis. “I’m extremely proud... Read more
MENLO PARK, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2020. Read more
MENLO PARK, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2020. Third Quarter 2020 Financial Results Total revenue for the third quarter of 2020 was $19.1 million, compared with $21.9 million for the same period of 2019. Instrument... Read more
Torrance, Calif. (November 2nd, 2020) – Phenomenex, Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, has announced that it will begin to directly serve customers in Thailand, effective November 2, 2020. The new office will be operated out of Bangkok. Phenomenex is a leading player in the... Read more
Latest testing strategy to increase the sample processing efficiency WALTHAM, Mass. –(BUSINESS WIRE)–Oct. 29, 2020– PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow sample pooling with PerkinElmer Read more
SAN DIEGO–(BUSINESS WIRE)—- $ILMN #ILMN–Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2020. Third quarter 2020 results reflect strong sequential growth: Revenue of $794 million, an increase of 26% compared to the second quarter of 2020 and a 12% decrease compared to $907 million in the prior... Read more
Reported net income of $37 million or $0.20 per share; adjusted net income of $114 million or $0.62 per share Revenue declined 6% on a reported basis, and 7% organically, impacted by COVID-19 Strong operating margin performance of 6% and 13% on a reported and adjusted basis, respectively, from disciplined execution on productivity and cost... Read more
Revenue of $964.0 million; 36% reported growth; 34% organic growth GAAP EPS from continuing operations of $1.57; Adjusted EPS of $2.09 WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 28, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended October 4, 2020. The Company reported... Read more